Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Omniab Inc (OABI)

Omniab Inc (OABI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 431,647
  • Shares Outstanding, K 117,615
  • Annual Sales, $ 34,160 K
  • Annual Income, $ -50,620 K
  • 60-Month Beta -0.12
  • Price/Sales 12.91
  • Price/Cash Flow N/A
  • Price/Book 1.46
Trade OABI with:

Options Overview Details

View History
  • Implied Volatility 150.37% ( +56.72%)
  • Historical Volatility 51.28%
  • IV Percentile 92%
  • IV Rank 60.04%
  • IV High 236.78% on 04/19/24
  • IV Low 20.51% on 02/08/24
  • Put/Call Vol Ratio 1.67
  • Today's Volume 16
  • Volume Avg (30-Day) 44
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 3,850
  • Open Int (30-Day) 4,114

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.18
  • Number of Estimates 4
  • High Estimate -0.13
  • Low Estimate -0.20
  • Prior Year -0.15
  • Growth Rate Est. (year over year) -20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.62 +1.38%
on 07/02/24
4.69 -21.75%
on 06/07/24
-0.67 (-15.44%)
since 05/31/24
3-Month
3.62 +1.38%
on 07/02/24
5.54 -33.79%
on 04/04/24
-1.61 (-30.49%)
since 04/02/24
52-Week
3.62 +1.38%
on 07/02/24
6.72 -45.35%
on 01/09/24
-1.36 (-27.04%)
since 06/30/23

Most Recent Stories

More News
OmniAb to Report First Quarter 2023 Financial Results on May 11

OmniAb, Inc. (Nasdaq: OABI) will report financial results for the three months ended March 31, 2023 before the open of the U.S. financial markets on Thursday, May 11, 2023 and will hold a conference call...

OABI : 3.67 (-1.87%)
OmniAb to Participate in Upcoming Investor Conferences in May

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in five upcoming investor conferences in May.

OABI : 3.67 (-1.87%)
OmniAb Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights

OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and 12 months ended December 31, 2022, and provided operating and partner program updates.

OABI : 3.67 (-1.87%)
LGND : 84.79 (-0.07%)
OmniAb to Report Fourth Quarter 2022 Financial Results on March 30

OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and 12 months ended December 31, 2022 after the close of the U.S. financial markets on Thursday, March 30, 2023 and will hold a...

OABI : 3.67 (-1.87%)
OmniAb to Participate in Three Upcoming Investor Conferences

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in three upcoming investor conferences.

OABI : 3.67 (-1.87%)
OmniAb Reports Third Quarter 2022 Financial Results and Business Highlights

OmniAb, Inc. (NASDAQ: OABI) reported financial results for the three and nine months ended September 30, 2022 and provided operating and program updates. OmniAb was part of Ligand Pharmaceuticals Incorporated...

OABI : 3.67 (-1.87%)
LGND : 84.79 (-0.07%)
AHPA : 6.13 (-9.26%)
OmniAb to Participate in Two Upcoming Investor Conferences

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in two upcoming investor conferences.

OABI : 3.67 (-1.87%)
OmniAb, Inc. to Ring Nasdaq Stock Market Opening Bell

OmniAb, Inc. (NASDAQ: OABI) today announced its Chief Executive Officer Matt Foehr will ring the opening bell of the Nasdaq Stock Market in a ceremony today at 9:30 a.m. Eastern time. He will be joined...

OABI : 3.67 (-1.87%)
OmniAb Announces Completion of Spin-Off and Business Combination

OmniAb, Inc. (NASDAQ: OABI) today announced the completion of the expected tax-free spin-off from Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and the subsequent business combination with Avista...

OABI : 3.67 (-1.87%)
LGND : 84.79 (-0.07%)
AHPA : 6.13 (-9.26%)

Business Summary

OmniAb Inc. discovery platform provides pharmaceutical industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. OmniAb Inc., formerly known as Avista Public Acquisition Corp. II, is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 3.85
2nd Resistance Point 3.80
1st Resistance Point 3.73
Last Price 3.67
1st Support Level 3.61
2nd Support Level 3.56
3rd Support Level 3.49

See More

52-Week High 6.72
Fibonacci 61.8% 5.53
Fibonacci 50% 5.17
Fibonacci 38.2% 4.80
Last Price 3.67
52-Week Low 3.62

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar